| 1 | Lymphocyte Subset Ratio Cannot Diagnose Immune Failure of a TKA. (Keeling P, Schneiderman BA, Lu C, Wilson ML, Schmalzried TP) J Arthroplasty 2022 Jul;37(7):1364-1368 2 Citations |
| 1 | Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. (Shah A, Storek J, Woolson R, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClercq S, Clair WS, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM) Rheumatology (Oxford) 2022 Oct 06;61(10):4155-4162 8 Citations |
| 2 | Single-cell lineage mapping of a diverse virus-specific naive CD4 T cell repertoire. (Khatun A, Kasmani MY, Zander R, Schauder DM, Snook JP, Shen J, Wu X, Burns R, Chen YG, Lin CW, Williams MA, Cui W) J Exp Med 2021 Mar 01;218(3) 51 Citations |
| 1 | Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. (Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR) Blood Adv 2019 Aug 13;3(15):2250-2263 45 Citations |
| 2 | X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis. (Gallagher J, Adams J, Hintermeyer M, Torgerson TR, Lopez-Guisa J, Ochs HD, Szabo S, Salib M, Verbsky J, Routes J) J Clin Immunol 2016 Aug;36(6):564-70 13 Citations |
| 1 | Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases. (Rao N, Mackinnon AC, Routes JM) Hum Pathol 2015 Sep;46(9):1306-14 106 Citations |
| 1 | PTEN is a negative regulator of NK cell cytolytic function. (Briercheck EL, Trotta R, Chen L, Hartlage AS, Cole JP, Cole TD, Mao C, Banerjee PP, Hsu HT, Mace EM, Ciarlariello D, Mundy-Bosse BL, Garcia-Cao I, Scoville SD, Yu L, Pilarski R, Carson WE 3rd, Leone G, Pandolfi PP, Yu J, Orange JS, Caligiuri MA) J Immunol 2015 Feb 15;194(4):1832-40 40 Citations |
| 1 | Coenzyme Q10 and immunity: A case report and new implications for treatment of recurrent infections in metabolic diseases. (Farough S, Karaa A, Walker MA, Slate N, Dasu T, Verbsky J, Fusunyan R, Canapari C, Kinane TB, Van Cleave J, Sweetser DA, Sims KB, Walter JE) Clin Immunol 2014 Dec;155(2):209-12 14 Citations |
| 1 | Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. (Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, Noel RJ, Verbsky JW, Freeman AF, Janssen E, Bonilla FA, Pechacek J, Chandrasekaran P, Browne SK, Agharahimi A, Gharib AM, Mannurita SC, Yim JJ, Gambineri E, Torgerson T, Tran DQ, Milner JD, Holland SM) J Allergy Clin Immunol 2013 Jun;131(6):1611-23 283 Citations |
| 1 | CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications. (Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, Spector N, Molina-Kirsch HF, Warnke RA, Levy R, Natkunam Y) Am J Pathol 2012 Sep;181(3):795-803 49 Citations |
| 2 | IQGAP1: a regulator of intracellular spacetime relativity. (Malarkannan S, Awasthi A, Rajasekaran K, Kumar P, Schuldt KM, Bartoszek A, Manoharan N, Goldner NK, Umhoefer CM, Thakar MS) J Immunol 2012 Mar 01;188(5):2057-63 41 Citations |
| 1 | Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. (de Vries E, European Society for Immunodeficiencies (ESID) members) Clin Exp Immunol 2012 Jan;167(1):108-19 159 Citations |
| 2 | The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. (Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ) Biol Blood Marrow Transplant 2010 Feb;16(2):253-62 27 Citations |
| 1 | The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. (Guo H, Samarakoon A, Vanhaesebroeck B, Malarkannan S) J Exp Med 2008 Sep 29;205(10):2419-35 93 Citations |
| 2 | Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. (Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, Dipersio JF) Biol Blood Marrow Transplant 2003 Nov;9(11):714-21 27 Citations |
| 1 | Transient stress lymphocytosis: an immunophenotypic characterization of the most common cause of newly identified adult lymphocytosis in a tertiary hospital. (Karandikar NJ, Hotchkiss EC, Mckenna RW, Kroft SH) Am J Clin Pathol 2002 May;117(5):819-25 36 Citations |
| 1 | Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits. (Murray PD, McGavern DB, Pease LR, Rodriguez M) Eur J Immunol 2002 Mar;32(3):606-15 37 Citations |
| 1 | Certain immune markers are not good indicators of mild to moderate biotin deficiency in rats. (Helm RM, Mock NI, Simpson P, Mock DM) J Nutr 2001 Dec;131(12):3231-6 5 Citations |
| 1 | Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attack. (Mosnaim AD, Kulaga H, Adams AJ, Wolf ME, Puente J, Freitag F, Diamond S) Cephalalgia 1998 May;18(4):197-201 23 Citations |
| 1 | Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy. (de Jong JL, Farner NL, Javorsky BR, Lindstrom MJ, Hank JA, Sondel PM) Clin Cancer Res 1998 May;4(5):1287-96 12 Citations |
| 1 | Psychological disturbance differentially alters CD4+ and CD8+ leukocytes in the blood and intrathecal compartments. (Hou FY, Coe CL, Erickson C) J Neuroimmunol 1996 Aug;68(1-2):13-8 10 Citations |
| 1 | Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously. (Whitehead RP, Friedman KD, Clark DA, Pagani K, Rapp L) Clin Cancer Res 1995 Oct;1(10):1145-52 14 Citations |
